​

Treace Medical Concepts (TMCI) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

TMCI Stock Forecast

Treace Medical Concepts (TMCI) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $3.00, with a high of $3.00 and a low of $3.00. This represents a 122.22% increase from the last price of $1.35.

- $6 $12 $18 $24 $30 High: $3 Avg: $3 Low: $3 Last Closed Price: $1.35

TMCI Stock Rating

Treace Medical Concepts stock's rating consensus is Hold, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (22.22%), 6 Hold (66.67%), 1 Sell (11.11%), and 0 Strong Sell (0.00%).

Hold
Total 9 0 1 6 2 Strong Sell Sell Hold Buy Strong Buy

TMCI Price Target Upside V Benchmarks

TypeNameUpside
StockTreace Medical Concepts122.22%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks31.16%

Price Target Trends

1M3M12M
# Anlaysts-25
Avg Price Target-$3.00$5.00
Last Closing Price$1.35$1.35$1.35
Upside/Downside-122.22%270.37%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26-14-16
Feb, 26-14-16
Jan, 26-14-16
Dec, 25-23-16
Nov, 25-24--6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 07, 2026Stifel Nicolaus$3.00$2.922.74%122.22%
Dec 18, 2025Richard NewitterTruist Financial$3.00$2.5418.11%122.22%
Nov 10, 2025Richard NewitterTruist Financial$4.00$3.863.63%196.30%
Oct 15, 2025Truist Financial$7.00$6.2012.90%418.52%
Sep 03, 2025Truist Financial$8.00$7.2510.34%492.59%
Mar 13, 2025Truist Financial$9.50$7.9419.65%603.70%
Feb 04, 2025Ryan ZimmermanBTIG$16.00$10.5152.24%1085.19%
Dec 31, 2024Ben HaynorLake Street$14.50$7.4494.89%974.07%
May 16, 2024Danielle AntalffyUBS$6.50$5.959.24%381.48%
Sep 21, 2022BTIG$28.00$23.9516.91%1974.07%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 08, 2025UBSNeutralNeutralhold
Feb 04, 2025BTIGBuyBuyupgrade
Jan 29, 2025Lake StreetBuyBuyhold
Dec 31, 2024Lake StreetBuyinitialise
Jul 15, 2024Morgan StanleyEqual-WeightEqual-Weighthold
May 16, 2024UBSBuyNeutraldowngrade
Dec 22, 2023Truist FinancialUnderperformUnderperformhold
Sep 21, 2022BTIGBuyBuyhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.38$-0.77$-0.81$-0.90$-0.93---
Avg Forecast$-0.29$-0.82$-0.80$-0.93$-0.74$-0.65$-0.72$-0.71
High Forecast$-0.29$-0.81$-0.72$-0.92$-0.67$-0.47$-0.71$-0.70
Low Forecast$-0.30$-0.83$-0.87$-0.94$-0.85$-0.76$-0.73$-0.72
Surprise %31.03%-6.10%1.25%-3.23%25.68%---

Revenue Forecast

$50M $110M $170M $230M $290M $350M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$94.42M$141.84M$187.12M$209.36M$212.69M---
Avg Forecast$93.08M$137.03M$185.27M$207.70M$225.68M$256.12M$259.40M$318.10M
High Forecast$95.40M$138.27M$185.32M$207.98M$228.23M$259.86M$262.86M$322.35M
Low Forecast$91.69M$136.30M$185.21M$207.34M$224.13M$252.39M$257.35M$315.58M
Surprise %1.44%3.51%1.00%0.80%-5.76%---

Net Income Forecast

$-60M $-51M $-42M $-33M $-24M $-15M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-20.55M$-42.81M$-49.53M$-55.74M$-59.00M---
Avg Forecast$-17.89M$-49.70M$-49.53M$-56.40M$-46.78M$-40.97M$-43.97M$-43.21M
High Forecast$-17.54M$-49.36M$-44.10M$-55.79M$-41.03M$-28.54M$-43.36M$-42.76M
Low Forecast$-18.47M$-50.29M$-52.68M$-57.02M$-51.58M$-46.37M$-44.57M$-43.95M
Surprise %14.90%-13.86%--1.17%26.11%---

TMCI Forecast FAQ

Is Treace Medical Concepts stock a buy?

Treace Medical Concepts stock has a consensus rating of Hold, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 6 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Treace Medical Concepts is a neutral investment for most analysts.

What is Treace Medical Concepts's price target?

Treace Medical Concepts's price target, set by 9 Wall Street analysts, averages $3 over the next 12 months. The price target range spans from $3 at the low end to $3 at the high end, suggesting a potential 122.22% change from the previous closing price of $1.35.

How does Treace Medical Concepts stock forecast compare to its benchmarks?

Treace Medical Concepts's stock forecast shows a 122.22% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (31.16%).

What is the breakdown of analyst ratings for Treace Medical Concepts over the past three months?

  • March 2026: 0% Strong Buy, 16.67% Buy, 66.67% Hold, 0% Sell, 16.67% Strong Sell.
  • February 2026: 0% Strong Buy, 16.67% Buy, 66.67% Hold, 0% Sell, 16.67% Strong Sell.
  • January 2026: 0% Strong Buy, 16.67% Buy, 66.67% Hold, 0% Sell, 16.67% Strong Sell.

What is Treace Medical Concepts’s EPS forecast?

Treace Medical Concepts's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.65, marking a -30.11% decrease from the reported $-0.93 in 2025. Estimates for the following years are $-0.72 in 2027, and $-0.71 in 2028.

What is Treace Medical Concepts’s revenue forecast?

Treace Medical Concepts's average annual revenue forecast for its fiscal year ending in December 2026 is $256.12M, reflecting a 20.42% increase from the reported $212.69M in 2025. The forecast for 2027 is $259.4M, and $318.1M for 2028.

What is Treace Medical Concepts’s net income forecast?

Treace Medical Concepts's net income forecast for the fiscal year ending in December 2026 stands at $-40.968M, representing a -30.57% decrease from the reported $-59.002M in 2025. Projections indicate $-43.968M in 2027, and $-43.205M in 2028.